IN2015DN02513A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN02513A IN2015DN02513A IN2513DEN2015A IN2015DN02513A IN 2015DN02513 A IN2015DN02513 A IN 2015DN02513A IN 2513DEN2015 A IN2513DEN2015 A IN 2513DEN2015A IN 2015DN02513 A IN2015DN02513 A IN 2015DN02513A
- Authority
- IN
- India
- Prior art keywords
- preparation
- compounds
- antibiotics
- ertapenem
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12188351 | 2012-10-12 | ||
PCT/EP2013/071252 WO2014057079A1 (en) | 2012-10-12 | 2013-10-11 | Preparation of ertapenem intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN02513A true IN2015DN02513A (sl) | 2015-09-11 |
Family
ID=47022553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2513DEN2015 IN2015DN02513A (sl) | 2012-10-12 | 2013-10-11 |
Country Status (9)
Country | Link |
---|---|
US (2) | US9546171B2 (sl) |
EP (1) | EP2906561A1 (sl) |
JP (1) | JP2015533142A (sl) |
KR (1) | KR20150065176A (sl) |
CN (1) | CN104703986A (sl) |
AU (1) | AU2013328585A1 (sl) |
CA (1) | CA2887098A1 (sl) |
IN (1) | IN2015DN02513A (sl) |
WO (1) | WO2014057079A1 (sl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2887098A1 (en) * | 2012-10-12 | 2014-04-17 | Sandoz Ag | Preparation of ertapenem intermediates |
CN113880839A (zh) * | 2021-11-01 | 2022-01-04 | 石药集团中诺药业(石家庄)有限公司 | 一种厄他培南钠粗品的合成新方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9202298D0 (en) * | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
AR008255A1 (es) | 1996-07-12 | 1999-12-29 | Merck & Co Inc | Procedimiento para sintetizar antibioticos de carbapenem |
WO1998057973A1 (en) | 1997-06-16 | 1998-12-23 | Merck & Co., Inc. | Stabilized carbapenem intermediates and synthetic use |
US5872250A (en) * | 1997-07-30 | 1999-02-16 | Merck & Co., Inc. | Process for synthesizing carbapenem antibiotics |
CA2457642C (en) | 2001-09-26 | 2009-01-06 | Merck & Co., Inc. | Crystalline forms of ertapenem sodium |
CN100457760C (zh) * | 2005-10-20 | 2009-02-04 | 上海交通大学 | 尔他培南钠盐的制备方法 |
US8293894B2 (en) | 2006-11-20 | 2012-10-23 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of carbapenem antibiotic |
JP2012525339A (ja) * | 2009-04-30 | 2012-10-22 | 石葯集団中奇制葯技▲術▼(石家庄)有限公司 | エルタペネムの中間体、エルタペネムを含む組成物およびそれらの調製方法 |
US8729260B2 (en) * | 2010-05-19 | 2014-05-20 | Savior Lifetec Corporation | Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem |
US20110288289A1 (en) * | 2010-05-19 | 2011-11-24 | Savior Lifetec Corporation | Preparation of Carbapenem Intermediate and Their Use |
KR20120007331A (ko) | 2010-07-14 | 2012-01-20 | 주식회사 경보제약 | 카르바페넴계 화합물들의 개선된 제조방법 |
CN101935321A (zh) * | 2010-07-20 | 2011-01-05 | 深圳市海滨制药有限公司 | 1β甲基碳青霉烯类抗生素的合成方法 |
CN102731502B (zh) | 2011-04-13 | 2016-08-03 | 石药集团中奇制药技术(石家庄)有限公司 | 一种碳青霉烯抗生素的制备方法 |
CN102351861A (zh) * | 2011-08-16 | 2012-02-15 | 湖南欧亚生物有限公司 | 一种厄他培南的工业化制备方法 |
CN102432611B (zh) * | 2011-11-09 | 2013-11-20 | 上海希迈医药科技有限公司 | 一种双保护厄他培南结晶体及其制备方法 |
CN102731508A (zh) * | 2012-07-03 | 2012-10-17 | 浙江海翔川南药业有限公司 | 一种晶体形式的厄他培南中间体及其制备方法和应用 |
CA2887098A1 (en) * | 2012-10-12 | 2014-04-17 | Sandoz Ag | Preparation of ertapenem intermediates |
-
2013
- 2013-10-11 CA CA2887098A patent/CA2887098A1/en not_active Abandoned
- 2013-10-11 WO PCT/EP2013/071252 patent/WO2014057079A1/en active Application Filing
- 2013-10-11 EP EP13774444.7A patent/EP2906561A1/en not_active Withdrawn
- 2013-10-11 US US14/434,550 patent/US9546171B2/en not_active Expired - Fee Related
- 2013-10-11 IN IN2513DEN2015 patent/IN2015DN02513A/en unknown
- 2013-10-11 JP JP2015536143A patent/JP2015533142A/ja active Pending
- 2013-10-11 KR KR1020157009049A patent/KR20150065176A/ko not_active Application Discontinuation
- 2013-10-11 CN CN201380053067.5A patent/CN104703986A/zh active Pending
- 2013-10-11 AU AU2013328585A patent/AU2013328585A1/en not_active Abandoned
-
2017
- 2017-01-17 US US15/407,741 patent/US20170166570A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US9546171B2 (en) | 2017-01-17 |
CN104703986A (zh) | 2015-06-10 |
US20170166570A1 (en) | 2017-06-15 |
EP2906561A1 (en) | 2015-08-19 |
AU2013328585A1 (en) | 2015-04-09 |
US20150274732A1 (en) | 2015-10-01 |
CA2887098A1 (en) | 2014-04-17 |
JP2015533142A (ja) | 2015-11-19 |
KR20150065176A (ko) | 2015-06-12 |
WO2014057079A1 (en) | 2014-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1213883A1 (zh) | 取代的嘧啶基和吡啶基吡咯並吡啶酮類、其製備方法及其作為激酶抑制劑的用途 | |
HK1207861A1 (en) | Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer bub1 | |
IL235944A0 (en) | β-lactamase inhibitor compounds, preparations containing them, methods for their preparation and their uses | |
IL231591A0 (en) | Converted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases | |
ZA201308395B (en) | Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/orbace2 inhibitors | |
AU2012213775A8 (en) | 7-azaindole derivatives | |
AU2012265219A8 (en) | Compounds containing hydrido-tricyano-borate anions | |
PL2922893T3 (pl) | Kompozycje utwardzane wilgocią, sposób ich wytwarzania i ich zastosowania | |
IN2014CN04050A (sl) | ||
CA2875305C (en) | Fbxo3 inhibitors | |
EP3082823A4 (en) | Iminothiadiazepane dioxide compounds as bace inhibitors, compositions, and their use | |
HK1199024A1 (zh) | 可作為 抑制物使用之新型嗎啉基衍生物 | |
WO2013155338A3 (en) | Substituted benzamides and their uses | |
PH12015500061A1 (en) | Method for preparing substituted triazolopyridines | |
GB201107985D0 (en) | Process | |
UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
AU2013347232A8 (en) | 3-Aminocyclopentane carboxamide derivatives | |
HK1207079A1 (en) | An improved process for the preparation of carbapenem antibiotic | |
IN2015DN02513A (sl) | ||
UA72478U (ru) | Применение полентара как средства фригопротекторного действия | |
UA80618U (en) | Use of n-steroylethanolamine as radiomodifier | |
MY168958A (en) | Intermediates and processes for preparing compounds | |
EP2903586B8 (en) | Composition | |
IN2013CH00453A (sl) | ||
AU2012903414A0 (en) | Composition |